Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vittoria Mastromarino

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|April 21, 2015
Integrated preclinical cardiovascular prevention: a new paradigm to face growing challenges of cardiovascular diseaseMassimo Volpe, Vittoria Mastromarino, Allegra Battistoni
Clinical Cardiology|April 16, 2015
Reducing Cardiovascular and Cancer Risk: How to Address Global Primary Prevention in Clinical PracticeAllegra Battistoni, Vittoria Mastromarino, Massimo Volpe
Clinical Science (London, England : 1979)|December 6, 2015
The natriuretic peptides system in the pathophysiology of heart failure: from molecular basis to treatmentMassimo Volpe, Marino Carnovali, Vittoria Mastromarino
Clinical Science (London, England : 1979)|October 9, 2010
Erythropoietin and the heart: facts and perspectivesVittoria Mastromarino, Massimo Volpe, Maria B Musumeci, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|July 2, 2013
Erythropoietin in cardiac disease: effective or harmful?Vittoria Mastromarino, Maria B Musumeci, Elena Conti, et al.
High Blood Pressure & Cardiovascular Prevention : the Official Journal of the Italian Society of Hypertension|June 14, 2017
Monotherapy and Dual Combination Therapies Based on Olmesartan: A Comprehensive Strategy to Improve Blood Pressure ControlMassimo Volpe, Caterina Santolamazza, Vittoria Mastromarino, et al.
High Blood Pressure & Cardiovascular Prevention : the Official Journal of the Italian Society of Hypertension|June 14, 2017
Triple Combination Therapies Based on Olmesartan: A Personalized Therapeutic Approach to Improve Blood Pressure ControlMassimo Volpe, Caterina Santolamazza, Vittoria Mastromarino, et al.
Current Heart Failure Reports|February 5, 2014
Polypharmacy in heart failure patientsVittoria Mastromarino, Matteo Casenghi, Marco Testa, et al.
Giornale Italiano Di Cardiologia (2006)|November 27, 2014
[Role of adherence to long-term drug therapy in patients with cardiovascular disease: an Italian intersocietary consensus document]Massimo Volpe, Luca Degli Esposti, Francesco Romeo, et al.
Clinical Science (London, England : 1979)|January 20, 2011
IGF-1 and atherothrombosis: relevance to pathophysiology and therapyElena Conti, Maria Beatrice Musumeci, Marco De Giusti, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|April 21, 2015
Integrated preclinical cardiovascular prevention: a new paradigm to face growing challenges of cardiovascular diseaseMassimo Volpe, Vittoria Mastromarino, Allegra Battistoni
Clinical Cardiology|April 16, 2015
Reducing Cardiovascular and Cancer Risk: How to Address Global Primary Prevention in Clinical PracticeAllegra Battistoni, Vittoria Mastromarino, Massimo Volpe
Clinical Science (London, England : 1979)|December 6, 2015
The natriuretic peptides system in the pathophysiology of heart failure: from molecular basis to treatmentMassimo Volpe, Marino Carnovali, Vittoria Mastromarino
Clinical Science (London, England : 1979)|October 9, 2010
Erythropoietin and the heart: facts and perspectivesVittoria Mastromarino, Massimo Volpe, Maria B Musumeci, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|July 2, 2013
Erythropoietin in cardiac disease: effective or harmful?Vittoria Mastromarino, Maria B Musumeci, Elena Conti, et al.
High Blood Pressure & Cardiovascular Prevention : the Official Journal of the Italian Society of Hypertension|June 14, 2017
Monotherapy and Dual Combination Therapies Based on Olmesartan: A Comprehensive Strategy to Improve Blood Pressure ControlMassimo Volpe, Caterina Santolamazza, Vittoria Mastromarino, et al.
High Blood Pressure & Cardiovascular Prevention : the Official Journal of the Italian Society of Hypertension|June 14, 2017
Triple Combination Therapies Based on Olmesartan: A Personalized Therapeutic Approach to Improve Blood Pressure ControlMassimo Volpe, Caterina Santolamazza, Vittoria Mastromarino, et al.
Current Heart Failure Reports|February 5, 2014
Polypharmacy in heart failure patientsVittoria Mastromarino, Matteo Casenghi, Marco Testa, et al.
Giornale Italiano Di Cardiologia (2006)|November 27, 2014
[Role of adherence to long-term drug therapy in patients with cardiovascular disease: an Italian intersocietary consensus document]Massimo Volpe, Luca Degli Esposti, Francesco Romeo, et al.
Clinical Science (London, England : 1979)|January 20, 2011
IGF-1 and atherothrombosis: relevance to pathophysiology and therapyElena Conti, Maria Beatrice Musumeci, Marco De Giusti, et al.
Pageof 3